Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c

Chemico-Biological Interactions

Volumn 101, Issue 3, 1996, Pages 165-174

  Elferink, Jan G R ^a   De Koster, Ben M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

cGMP; Endothelin receptors; Migration; Neutrophil; Sarafotoxin

Indexed keywords

6 [2 [4 [(4 FLUOROPHENYL)PHENYLMETHYLENE] 1 PIPERIDYL]ETHYL] 7 METHYL 5H THIAZOLO[3,2 A]PYRIMIDIN 5 ONE; CALCIUM; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1 DERIVATIVE; ENDOTHELIN 1 [11-21]; ENDOTHELIN RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; LEUKOTRIENE B4; PHORBOL 13 ACETATE 12 MYRISTATE; SARAFOTOXIN S6C; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN;

EID: 0030572717     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-2797(96)03725-8     Document Type: Article

References (23)

1. [1] E.E. Anggard, R.M. Botting and J.R. Vane, Endothelins. Blood Vessels, 27 (1990) 269-281.
2. [2] M.C. Simonson, Endothelins: multifunctional renal peptides. Physiol. Revs., 73 (1993) 375-411.
3. [3] G.M. Rubanyi and M.A. Polokoff, Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Revs., 46 (1994) 325-415.
4. [4] Y. Kloog, M. Sokolovsky, E. Kochva, Z. Wollberg and A. Bdolah, Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science, 242 (1988) 268-270.
5. [5] M. Sokolovski, Endothelins and sarafotoxins: physiological regulation, receptor subtypes, and membrane signaling. Pharmacol. Ther., 54 (1992) 129-149.
6. [6] M. Sokolovski, Structure-function relationships of endothelins and sarafotoxins and their receptor subtypes. J. Neurochem., 59 (1992) 809-821.
7. [7] T. Masaki, J.R. Vane and P.M. Vanhoutte, International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev., 46 (1994) 137-142.
8. [8] D.L. Williams, K.L. Jones, D.J. Pettibone, E.V. Lis and D.J. Clineschmidt, Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Bichem. Biophys. Res. Commun., 175 (1991) 556-561.
9. [9] K. Ishida, K. Takeshige and S. Minakami, Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem. Biophys. Res. Commun., 173 (1990) 496-500.
10. [10] J.G.R. Elferink and B.M. de Koster, Endothelin-induced activation of neutrophil migration. Biochem. Pharmacol., 48 (1994) 865-871.
11. [11] J.G.R. Elferink and B.M. de Koster, Stimulation and inhibition of neutrophil chemotaxis by endothelin-3. J. Cardiovasc. Pharmacol., 26 (1995) S142-S144.
12. [12] C.D. Wright, W.L. Cody, J.B. Dunbar, A.M. Doherty, G.P. Hingorani and S.T. Rapundalo, Characterization of endothelins as chemoattractants for human neutrophils. Life Sci., 55 (1994) 1633-1641.
13. [13] J.G.R. Elferink and B.M. de Koster, The effect of endothelin-2 (ET-2) on migration and changes in cytosolic free calcium of neutrophils. Naunyn-Schmiedeberg's Arch. Pharmacol., 353 (1996) 130-135.
14. [14] J.G.R. Elferink and B.M. de Koster, The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. Eur. J. Pharmacol., 246 (1993) 157-161.
15. [15] S.V. Boyden, The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med., 115 (1962) 453-466.
16. [16] S.H. Zigmond and J.G. Hirsch, Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med., 137 (1973) 387-410.
17. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260 (1985) 3440-3450.
18. [18] T.M. Wright, R.D. Hoffman, J. Nishijima, L. Jakoi, R. Snyderman and H.S. Shin, Leukocyte chemoattraction by 1,2-diacylglycerol. Proc. Natl. Acad. Sci., USA 85 (1988) 1869-1873.
19. [19] G.J.J.C. Boonen, B.M. de Koster, J. Van Steveninck and J.G.R. Elferink, Neutrophil chemotaxis induced by the diacylglycerol kinase inhibitor R59022. Biochim. Biophys. Acta 1178 (1993) 97-102.
20. [20] W.L. Gabler, W.W. Bullock and H.R. Creamer, Phorbol myristate acetate induction of chemotactic migration of human polymorphonuclear neutrophils. Inflammation, 17 (1993) 521-530.
21. B receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation. Eur. J. Pharmacol., 231 (1993) 371-374.
22. [22] J.G.R. Elferink, G.J.J.C. Boonen and B.M. de Koster, The role of calcium in neutrophil migration: the effect of calcium and calcium antagonists in electroporated neutrophils. Biochem. Biophys. Res. Commun., 182 (1992) 864-869.
23. [23] S.H. Zigmond, J.L. Slonczewski, M.W. Wilde and M. Carson, Polymorphonuclear leukocyte locomotion is insensitive to lowered cytoplasmic calcium levels. Cell Motility Cytoskeleton 9 (1988) 184-189.